Aortic velocity propagation: A novel echocardiographic method in predicting atherosclerotic coronary artery disease

Pakala Vasudeva Chetty1, Durgaprasad Rajasekhar1, Velam Vanajakshamma1

  • 1Department of Cardiology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, IndiaaIndia.

Insights

Aortic velocity propagation (AVP) and carotid intima-media thickness (CIMT) effectively predict coronary artery disease (CAD) burden. AVP shows promise as a noninvasive bedside tool for assessing atherosclerotic disease and guiding preventive cardiovascular therapy.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Atherosclerosis is a leading cause of global cardiovascular disease mortality.
  • Early detection and noninvasive assessment of atherosclerosis are crucial for disease management.
  • Aortic velocity propagation (AVP) quantifies aortic stiffness, reflecting atherosclerotic changes.

Purpose of the Study:

  • To evaluate the utility of AVP in predicting coronary artery disease (CAD) burden.
  • To compare AVP's predictive capability with carotid intima-media thickness (CIMT), a known atherosclerosis marker.
  • To assess the correlation between AVP, CIMT, and the SYNTAX score in patients undergoing coronary angiography.

Main Methods:

  • A cross-sectional study involving 100 patients who underwent coronary angiography.
  • AVP measured using color M-mode echocardiography.
  • CIMT measured using Philips QLAB-IMT software.
  • Coronary artery disease significance defined by >50% diameter stenosis.

Main Results:

  • Significant CAD was present in 69% of patients.
  • Patients with significant CAD exhibited significantly lower AVP and higher CIMT compared to those without.
  • AVP strongly and negatively correlated with CIMT (r=-0.836) and SYNTAX score (r=-0.803).
  • CIMT showed a significant positive correlation with the SYNTAX score (r=0.828).

Conclusions:

  • Both AVP and CIMT are robust predictors of CAD burden.
  • AVP demonstrates potential as a valuable, noninvasive bedside tool for assessing atherosclerotic burden.
  • AVP can aid in guiding preventive strategies for cardiovascular disease.
Abstract